🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide SYNCHRONIZE Phase 3 — November 2025 Page 7

Survodutide SYNCHRONIZE Phase 3 — November 2025

ZaraB_AL Thu, Sep 12, 2024 at 4:18 AM 56 replies 2,243 viewsPage 7 of 12
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Dec 11, 2024 at 5:43 AM#31

Adding the clinical framing, because it changes how the question reads. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

That is the short version; the long version is somebody else's post.

16 14DebRD_ATL, KristenIndy, MarkLI_maint and 13 others
Reply Quote Save Share Report
tony_orlando
Member
234
1,123
Nov 2024
Orlando, FL
Dec 18, 2024 at 4:54 AM#32
GenomicsKate said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Same experience, arrived at from the opposite direction.

17 15JakeSmashed95, NauseaFreeNow, SteveThurs and 14 others
Reply Quote Save Share Report
ben_calgary
Member
245
1,123
Oct 2024
Calgary, CA
Dec 25, 2024 at 4:01 AM#33
GenomicsKate said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Coming at GenomicsKate’s question from a different direction. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

Ask again with the specifics and you will get a better answer than this one.

18 16ZaraB_AL, JakeSmashed95, NauseaFreeNow and 15 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Jan 1, 2025 at 3:04 AM#34

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

19 17TirzTom, TrialTracker_MD, JennaRN and 16 others
Reply Quote Save Share Report
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Jan 8, 2025 at 2:03 AM#35

One thing that is still open after GenomicsKate’s answer:

What did you change at the same time, and can you separate the two now?

Last edited: Jan 8, 2025 at 5:03 AM
20 18EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 17 others
Reply Quote Save Share Report
15678912

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register